Overcoming the Challenges of AI Antibody Analysis
Cracking the molecular code
False
Advertisement
Related Content
Development & Clinical
Biopharma
Interviews
Musings from The Power List: Andres Sirulnik
October 5, 2026
4 min read
Regeneron's L. Andres Sirulnik explains why modernizing clinical trials is as important as developing new medicines
Biopharma
Development & Clinical
Interviews
Musings from The Power List: Renee Aguiar-Lucander
September 28, 2026
2 min read
Renee Aguiar-Lucander argues that faster clinical trials and more pragmatic regulation are essential to bringing medicines to patients sooner
Biopharma
Business & Trends
Technology & Manufacturing
The Manufacturing Questions Facing Chinese Biotech
September 9, 2026
5 min read
Lonza’s Wayne Wen discusses the growing maturity of China’s drug development and manufacturing ecosystem – and what companies need to compete internationally
Biopharma
Biopharma
Regulation & Standards
China’s Biopharma Homecoming
September 1, 2026
7 min read
Chinese biopharma leaders are returning from the West to build a more confident – and innovative – global industry, says Cyagen’s Lance Han